Mangalam Drugs And Organics Ltd.

96.60 +0.50 ▲0.5%

05 December 2023, 11:16:55 AM
Volume: 19,790

Company Profile

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.mangalamdrugs.com
Market Cap 152.68 Cr.
Enterprise Value(EV) 222.65 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -10.78 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-09
Industry PE 38.73 Trailing Twelve Months Ending 2023-09
Book Value / Share 87.77 Trailing Twelve Months Ending 2023-09
Price to Book Value 1.10 Calculated using Price: 96.46
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.58 Cr. 15,828,248 Shares
FaceValue 10
About Mangalam Drugs And Organics Ltd.
Mangalam Drugs & Organics Limited (Mangalam) is a part of the MangalamGroup promoted by Dhoot family in 1972 as Advent Pharma PrivateLimited with a view to set up a plant for manufacture of organic andinorganic chemicals. Mangalam Drugs & Organics commmenced its business in 1977.

Mangalam Drugs And Organics Ltd. Delivery

Delivered Qty
Traded Qty

Mangalam Drugs And Organics Ltd. Performance

1 Day
+0.52%
1 Week
-0.16%
1 Month
-4.40%
3 Month
-8.26%
6 Month
-6.80%
1 Year
-32.52%
2 Year
-22.72%
5 Year
+32.06%
10 Year
+2000%

Mangalam Drugs And Organics Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 23.36 38.91 32.11 20.99 -8.05 8.27 23.83 13.97 0.84
Return on Capital Employed (%) 15.69 29.14 30.18 25.35 1.76 10.66 28.01 18.34 6.56
Return on Assets (%) 4.16 9.73 12.76 9.56 -3.67 3.73 11.31 6.64 0.37

Mangalam Drugs And Organics Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 29 62 86 104 96 104 131 151 152 139
Non Curr. Liab. 41 25 26 23 25 17 24 48 42 39
Curr. Liab. 99 73 78 100 91 109 109 130 165 209
Minority Int.
Equity & Liab. 170 160 190 227 211 231 264 328 360 387
Non Curr. Assets 54 60 94 104 106 111 130 143 153 152
Curr. Assets 116 100 96 123 105 119 134 185 207 235
Misc. Exp. not W/O
Total Assets 170 160 190 227 211 231 264 328 360 387

Mangalam Drugs And Organics Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 221 295 303 279 228 282 385 451 372 323
Other Income 0 0 0 1 0 1 0 0 0
Total Income 221 295 303 280 228 284 385 451 373 324
Total Expenditure -200 -258 -257 -233 -218 -259 -327 -402 -347 -318
PBIDT 20 38 46 48 10 25 58 49 26 6
Interest -10 -9 -10 -12 -9 -10 -9 -11 -13 -13
Depreciation -4 -4 -5 -7 -7 -8 -9 -10 -11 -13
Taxation 0 -8 -9 -9 -2 2 -12 -8 -1 3
Exceptional Items
PAT 6 16 22 20 -8 8 28 20 1 -17
Adjusted EPS 5 11 14 13 -5 5 18 12 1 -11

Mangalam Drugs And Organics Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 7 14 22 43 25 22 31 28 26 40
Cash Fr. Inv. -2 -4 -11 -39 -16 -9 -7 -31 -27 -22
Cash Fr. Finan. -5 -10 -11 -3 -9 -11 -23 3 3 -17
Net Change 0 1 0 0 0 1 0 -1 1 1
Cash & Cash Eqvt 0 1 1 1 0 1 2 1 2 3

Mangalam Drugs And Organics Ltd. Shareholding Pattern

9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 50.53 50.53 50.53 50.42 50.42 50.32 50.32 50.32 50.32
Public 49.47 49.47 49.47 49.58 49.58 49.68 49.68 49.68 49.68
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 11.59 16.88 19.98 16.97 16.22 16.65 20.93 20.04 17.52

Mangalam Drugs And Organics Ltd. Announcements

Fri, 10 Nov 2023
Copy of Newspaper Publication
Mangalam Drugs And Organics Limited has informed the Exchange about Copy of Newspaper Publication
Thu, 09 Nov 2023
Outcome of Board Meeting
Mangalam Drugs And Organics Limited has informed the Exchange regarding Board meeting held on November 08, 2023.
Thu, 09 Nov 2023
Financial Result Updates
Mangalam Drugs And Organics Limited has submitted to the Exchange, the financial results for the period ended September 30, 2023.

Mangalam Drugs And Organics Ltd. Technical Scans

Mon, 04 Dec 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week Low Zone Close Within 52 Week Low Zone

Mangalam Drugs And Organics Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 295,466.10 1,232.00 +0.1%
Divi's Laboratories Ltd. 100,787.80 3,748.00 -1.3%
Cipla Ltd. 98,218.21 1,222.50 +0.5%
Dr. Reddy's Laboratories Ltd. 95,898.45 5,780.65 +0.4%
Apollo Hospitals Enterprise Ltd. 80,842.20 5,584.65 -0.7%
Mankind Pharma Ltd. 76,792.80 1,941.55 +0.9%
Torrent Pharmaceuticals Ltd. 72,137.95 2,145.35 +0.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.56 1,232.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-09 75.68 3,748.00 -1.3%
Cipla Ltd. Consolidated 2023-09 28.44 1,222.50 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.84 5,780.65 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 115.91 5,584.65 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 59.91 1,941.55 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 54.08 2,145.35 +0.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.94 1,232.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-09 7.95 3,748.00 -1.3%
Cipla Ltd. Consolidated 2023-09 3.96 1,222.50 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.76 5,780.65 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.44 5,584.65 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 9.11 1,941.55 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.76 2,145.35 +0.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,232.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,748.00 -1.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,222.50 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,780.65 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,584.65 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,941.55 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,145.35 +0.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,232.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,748.00 -1.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,222.50 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,780.65 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,584.65 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,941.55 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,145.35 +0.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,232.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,748.00 -1.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,222.50 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,780.65 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,584.65 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,941.55 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,145.35 +0.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,232.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,748.00 -1.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,222.50 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,780.65 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,584.65 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,941.55 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,145.35 +0.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,232.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,748.00 -1.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,222.50 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,780.65 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,584.65 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,941.55 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,145.35 +0.6%

Mangalam Drugs And Organics Ltd. FAQ's

What is Mangalam Drugs&Org. share price?

Can I buy Mangalam Drugs&Org. shares now?

What is the Market Cap of Mangalam Drugs&Org.?

What are the key metrics to analyse Mangalam Drugs&Org.?

What is the 52 Week High and Low of Mangalam Drugs&Org.?

What is the trend of Mangalam Drugs&Org. share price?